A new Australian collaborative Autism CRC study, led by Mater Research and The University of Queensland, has challenged the growing
New study challenges the popular belief that gut microbiome drives autism
Home ยป
Study highlights the need for caution while using CRISPR-based gene therapies
A comprehensive study-;conducted by researchers at Sanford Burnham Prebys, the National Cancer Institute (NCI) and other groups-;has shown that gene
Study paves the way for a better understanding of muscle injury
Researchers from the INCLIVA Health Research Institute, the Clinical Hospital of Valencia, and the University of Valencia (UV) have participated
Microtubule regulatory protein inhibits early HIV-1 infection, study finds
Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection, according to findings
Supercoiling and looping can transmit mechanical stress along the DNA backbone, research shows
When people think of DNA, they visualize a string-like double helix structure. In reality, the DNA double helix in cells
Study shows how oncology practices change after durvalumab approval for unresectable stage III NSCLC patients
A study presented today at the IASLC 2021 World Conference on Lung Cancer suggests how oncology practices in the United
Are bat retroviruses a threat to humans?
Bats have long been known as important hosts of zoonotic viral pathogens. Zoonotic viruses that bats transmit are capable of
Activated mast cell disorders potentially linked to SARS-CoV-2 immunity
A rare set of immune diseases called clonal mast cell activation disorders (cMCADs) may be associated with strong immunity to
Temperature variations could have driven the division of protocells
A simple mechanism could underlie the growth and self-replication of protocells-;putative ancestors of modern living cells-;suggests a study publishing September
New prediction model can identify NSCLC patients who are not likely to respond to immunotherapy
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in clinical practice to treat non-small